Glenmark Prescribed drugs Ltd soars 2.51%, rises for third straight session
Pharmaceuticals

Glenmark Prescribed drugs Ltd soars 2.51%, rises for third straight session



Glenmark Prescribed drugs Ltd is quoting at Rs 400.2, up 2.51% on the day as on 12:49 IST on the NSE. The inventory is down 39.85% in final one yr as in comparison with a 3.28% leap in NIFTY and a 13.31% leap within the Nifty Metallic index.

Glenmark Prescribed drugs Ltd is up for a 3rd straight session as we speak. The inventory is quoting at Rs 400.2, up 2.51% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up round 0.44% on the day, quoting at 16204.3. The Sensex is at 54436.06, up 0.48%. Glenmark Prescribed drugs Ltd has gained round 1.16% in final one month.

In the meantime, Nifty Metallic index of which Glenmark Prescribed drugs Ltd is a constituent, has gained round 0.14% in final one month and is presently quoting at 12389.7, up 0.48% on the day. The amount within the inventory stood at 3.96 lakh shares as we speak, in comparison with the day by day common of 6.91 lakh shares in final one month.

The benchmark July futures contract for the inventory is quoting at Rs 395.7, up 0.94% on the day. Glenmark Prescribed drugs Ltd is down 39.85% in final one yr as in comparison with a 3.28% leap in NIFTY and a 13.31% leap within the Nifty Metallic index.

The PE of the inventory is 6.7 based mostly on TTM earnings ending March 22.

Powered by Capital Market – Dwell Information

(This story has not been edited by Enterprise Customary workers and is auto-generated from a syndicated feed.)

Pricey Reader,

Enterprise Customary has all the time strived laborious to offer up-to-date data and commentary on developments which are of curiosity to you and have wider political and financial implications for the nation and the world. Your encouragement and fixed suggestions on the way to enhance our providing have solely made our resolve and dedication to those beliefs stronger. Even throughout these troublesome instances arising out of Covid-19, we proceed to stay dedicated to retaining you knowledgeable and up to date with credible information, authoritative views and incisive commentary on topical problems with relevance.

We, nonetheless, have a request.

As we battle the financial impression of the pandemic, we’d like your help much more, in order that we are able to proceed to give you extra high quality content material. Our subscription mannequin has seen an encouraging response from a lot of you, who’ve subscribed to our on-line content material. Extra subscription to our on-line content material can solely assist us obtain the targets of providing you even higher and extra related content material. We imagine in free, honest and credible journalism. Your help by means of extra subscriptions can assist us practise the journalism to which we’re dedicated.

Assist high quality journalism and subscribe to Enterprise Customary.

Digital Editor